This individualized approach enhances patient outcomes and satisfaction, leading to higher adherence and long-term success
Two studies reported that carnitine levels may decline in individuals as they progress to MCI and Alzheimer's disease [5][6]
Why PFAS are considered endocrine disruptors [1:19:45]
Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition and cytochrome c release
Genetic factors influence individual tolerance, which is why personalized approaches yield better outcomes
DECLARATIONS Authors contributions Developed the model, ran simulations and analyses, interpreted the findings, and contributed to the writing and editing of the manuscript: Cruikshank A, Reed MC, Nijhout HF Availability of data and materials Computer models and codes used in this paper can be obtained from the authors by request